MedPath

上海上药信谊药厂有限公司

Ownership
-
Established
1993-10-23
Employees
-
Market Cap
-
Website
www.sphsine.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

305

NMPA:305

Drug Approvals

Omeprazole and Sodium Bicarbonate for Suspension(II)

Product Name
奥美拉唑碳酸氢钠干混悬剂(Ⅱ)
Approval Number
国药准字H20253507
Approval Date
Mar 4, 2025
NMPA

阿昔洛韦片

Approval Number
国药准字H10890044
Approval Date
Aug 15, 2024
NMPA

烟酸片

Approval Number
国药准字H31021547
Approval Date
Aug 15, 2024
NMPA

盐酸普罗帕酮片

Approval Number
国药准字H31020492
Approval Date
Aug 9, 2024
NMPA

Erythromycin Ethylsuccinate Tablets

Product Name
琥乙红霉素片
Approval Number
国药准字H20058658
Approval Date
Aug 5, 2024
NMPA

阿司匹林肠溶片

Approval Number
国药准字H31022423
Approval Date
Aug 5, 2024
NMPA

地高辛片

Approval Number
国药准字H31020678
Approval Date
Jul 24, 2024
NMPA

甲硝唑片

Approval Number
国药准字H31021421
Approval Date
Jul 9, 2024
NMPA

硫唑嘌呤片

Approval Number
国药准字H31021423
Approval Date
Jul 9, 2024
NMPA

氢氯噻嗪片

Approval Number
国药准字H31020778
Approval Date
Jun 20, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 31
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.